HAE insiders

18 insiders have filed at HAE since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Simon, ChristopherPresident & CEO375.5k0.799%
Basil Michelle LEVP And General Counsel42.3k0.09%5 sells $1.5M
Llorens JosepEVP, Global Manufacturing30.9k0.066%4 sells $689k
Miller Laurie A.SVP, Human Resources28.9k0.062%
Darecca JamesEVP, Chief Financial Officer28.3k0.06%
Dockendorff Charles JDirector25.0k0.053%1 sells $896k
Abernathy Robert EDirector25.0k0.053%
Kroll Mark WDirector24.8k0.053%1 buys $99k
Lingamneni AnilaEVP, Chief Technology Officer21.3k0.045%4 sells $626k
Zane Ellen MDirector19.4k0.041%
Strong Stewart WPresident, Global Hospital18.2k0.039%5 sells $1.3M
Pomeroy ClaireDirector16.9k0.036%
Coyle Michael JDirector15.4k0.033%
Johnson Lloyd EmersonDirector12.9k0.028%
Galvin RoyEVP, Chief Commercial Officer12.8k0.027%
Bryant Diane MDirector7.1k0.015%
Chan FrankEVP, Chief Operating Officer5.7k0.012%
Maunsell Farris MaryanneVP, Chief Accounting Officer4.5k0.01%

Full register at boothcheck.com/insiders/HAE. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

HAE institutional holders · HAE research report